• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌:当前的治疗方法及未来趋势。

Breast cancer: Actual methods of treatment and future trends.

作者信息

Murawa Paweł, Murawa Dawid, Adamczyk Beata, Połom Karol

机构信息

Oncological and General Surgery Department I, Greater Poland Cancer Centre, Poznań, Poland ; Cancer Pathology Department, Oncology Department, Poznań University of Medical Sciences, Poland.

Oncological and General Surgery Department I, Greater Poland Cancer Centre, Poznań, Poland.

出版信息

Rep Pract Oncol Radiother. 2014 Jan 23;19(3):165-72. doi: 10.1016/j.rpor.2013.12.003. eCollection 2014 May.

DOI:10.1016/j.rpor.2013.12.003
PMID:24936340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4056541/
Abstract

The recent ten to twenty years have seen a substantial progress in the diagnosis and treatment of breast cancer. A rapid development of various curative options has led to the improvement of treatment outcomes, while paying more and more attention to the aspects of quality of life and cosmetic effect. In our publication, we wish to outline certain trends in the development of modern treatment of breast cancer. Among topics discussed are new forms of molecular diagnostics, new approach to the idea of sentinel node biopsy, as well as new techniques for delivery of medical procedures, the increasing use of nomograms, progress in the techniques of breast conservative treatment, modern approach to occult breast lesions, the increasing use of neoadjuvant treatment and intraoperative radiotherapy.

摘要

在最近的十到二十年里,乳腺癌的诊断和治疗取得了重大进展。各种治疗方案的迅速发展带来了治疗效果的改善,同时越来越关注生活质量和美容效果等方面。在我们的出版物中,我们希望概述现代乳腺癌治疗发展的某些趋势。讨论的主题包括分子诊断的新形式、前哨淋巴结活检理念的新方法、医疗程序实施的新技术、诺模图的使用增加、保乳治疗技术的进展、隐匿性乳腺病变的现代处理方法、新辅助治疗和术中放疗的使用增加。

相似文献

1
Breast cancer: Actual methods of treatment and future trends.乳腺癌:当前的治疗方法及未来趋势。
Rep Pract Oncol Radiother. 2014 Jan 23;19(3):165-72. doi: 10.1016/j.rpor.2013.12.003. eCollection 2014 May.
2
A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study.非触及性乳腺癌的改良前哨淋巴结及隐匿性病变定位(SNOLL)技术:一项初步研究
J Exp Clin Cancer Res. 2015 Oct 6;34:113. doi: 10.1186/s13046-015-0230-x.
3
High-resolution, handheld camera use for occult breast lesion localization plus sentinel node biopsy (SNOLL): a single-institution experience with 186 patients.用于隐匿性乳腺病变定位及前哨淋巴结活检的高分辨率手持式相机(SNOLL):186例患者的单机构经验
Surgeon. 2015 Apr;13(2):69-72. doi: 10.1016/j.surge.2013.10.005. Epub 2013 Nov 21.
4
Preliminary experience in sentinel node and occult lesion localization (SNOLL) technique-One center study.前哨淋巴结和隐匿性病变定位(SNOLL)技术的初步经验——单中心研究。
Rep Pract Oncol Radiother. 2011 Oct 15;16(6):221-6. doi: 10.1016/j.rpor.2011.08.004. eCollection 2011.
5
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.前哨淋巴结活检在乳腺癌新辅助化疗后是准确的。
J Clin Oncol. 2000 Oct 15;18(20):3480-6. doi: 10.1200/JCO.2000.18.20.3480.
6
Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.对于初诊时记录为淋巴结阳性的乳腺癌患者,新辅助化疗后进行前哨淋巴结活检是准确的。
Ann Surg Oncol. 2007 Oct;14(10):2946-52. doi: 10.1245/s10434-007-9403-y. Epub 2007 May 19.
7
An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.早期乳腺癌诊断的一种原创方法:对不可触及病变和前哨淋巴结定位使用相同的放射性药物。
Eur J Nucl Med. 2001 Nov;28(11):1589-96. doi: 10.1007/s002590100601.
8
[Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer].[乳腺癌前哨淋巴结活检与新辅助治疗]
Bull Cancer. 2017 Oct;104(10):892-901. doi: 10.1016/j.bulcan.2017.08.003. Epub 2017 Sep 8.
9
Specification of potential indications and contraindications of sentinel lymph node biopsy in breast cancer.乳腺癌前哨淋巴结活检潜在适应证和禁忌证的规范
Recent Results Cancer Res. 2000;157:228-36. doi: 10.1007/978-3-642-57151-0_20.
10
Sentinel lymph node biopsy in the management of breast cancer.前哨淋巴结活检在乳腺癌治疗中的应用
Indian J Cancer. 2003 Apr-Jun;40(2):60-6.

引用本文的文献

1
The Therapeutic Potential of Baicalin and Baicalein in Breast Cancer: A Systematic Review of Mechanisms and Efficacy.黄芩苷和黄芩素在乳腺癌中的治疗潜力:机制与疗效的系统评价
Curr Issues Mol Biol. 2025 Mar 11;47(3):181. doi: 10.3390/cimb47030181.
2
Differentiating Primary and Recurrent Lesions in Patients with a History of Breast Cancer: A Comprehensive Review.乳腺癌病史患者原发性和复发性病变的鉴别:一项综述。
Galen Med J. 2024 Apr 22;13:e3340. doi: 10.31661/gmj.v13i.3340. eCollection 2024.
3
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.ER+ 乳腺癌强烈依赖 MCL-1 和 BCL-xL 抗凋亡蛋白。
Cells. 2021 Jul 2;10(7):1659. doi: 10.3390/cells10071659.
4
The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors.健康症状对早期乳腺癌幸存者健康相关生活质量的影响。
Breast Cancer Res Treat. 2019 Dec;178(3):703-711. doi: 10.1007/s10549-019-05433-3. Epub 2019 Sep 11.
5
Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment.伤口渗出液会影响乳腺癌细胞系中miR-21、miR-155和miR-221的表达,而术中放射治疗可部分消除这种影响。
Oncol Lett. 2017 Oct;14(4):4029-4036. doi: 10.3892/ol.2017.6718. Epub 2017 Aug 3.
6
Effect of surgical wound fluids after intraoperative electron radiotherapy on the cancer stem cell phenotype in a panel of human breast cancer cell lines.术中电子放疗后手术伤口渗出液对一组人乳腺癌细胞系中癌症干细胞表型的影响。
Oncol Lett. 2016 Nov;12(5):3707-3714. doi: 10.3892/ol.2016.5167. Epub 2016 Sep 21.
7
Practical issues regarding angular and energy response in in vivo intraoperative electron radiotherapy dosimetry.关于体内术中电子放射治疗剂量测定中角度和能量响应的实际问题。
Rep Pract Oncol Radiother. 2017 Jan-Feb;22(1):55-67. doi: 10.1016/j.rpor.2016.09.009. Epub 2016 Oct 19.
8
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年79种行为、环境与职业及代谢风险或风险群组的全球、区域和国家比较风险评估:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1659-1724. doi: 10.1016/S0140-6736(16)31679-8.
9
Pre and post radiotherapy serum oxidant/antioxidant status in breast cancer patients: Impact of age, BMI and clinical stage of the disease.乳腺癌患者放疗前后血清氧化/抗氧化状态:年龄、体重指数和疾病临床分期的影响
Rep Pract Oncol Radiother. 2016 May-Jun;21(3):141-8. doi: 10.1016/j.rpor.2015.12.009. Epub 2016 Feb 10.
10
The appropriate axillary procedure after a positive sentinel node in breast cancer patients: the "Hôpital Tenon" score revisited. A two-institution study.乳腺癌患者前哨淋巴结阳性后的合适腋窝手术:重新审视“特农医院”评分。一项双机构研究。
Clin Transl Oncol. 2016 Nov;18(11):1098-1105. doi: 10.1007/s12094-016-1487-z. Epub 2016 Feb 26.

本文引用的文献

1
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.肿瘤完全缓解通过亚组更有效地预测无复发生存:来自 I-SPY 1 试验——CALGB 150007/150012、ACRIN 6657 的结果。
J Clin Oncol. 2012 Sep 10;30(26):3242-9. doi: 10.1200/JCO.2011.39.2779. Epub 2012 May 29.
2
Breast cancer sentinel lymph node mapping using near infrared guided indocyanine green and indocyanine green--human serum albumin in comparison with gamma emitting radioactive colloid tracer.近红外荧光吲哚菁绿和吲哚菁绿-人血清白蛋白联合放射性胶体示踪剂在乳腺癌前哨淋巴结定位中的应用比较
Eur J Surg Oncol. 2012 Feb;38(2):137-42. doi: 10.1016/j.ejso.2011.11.004. Epub 2011 Nov 29.
3
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase.EORTC 10041/BIG 03-04 MINDACT 试验是可行的:试验前期的结果。
Eur J Cancer. 2011 Dec;47(18):2742-9. doi: 10.1016/j.ejca.2011.09.016. Epub 2011 Nov 1.
4
Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials.既定预后因素和分子亚型对非常年轻乳腺癌患者的影响:四项 EORTC 随机对照试验的汇总分析。
Breast Cancer Res. 2011 Jun 24;13(3):R68. doi: 10.1186/bcr2908.
5
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.前瞻性 transGEICAM 研究 21 基因复发评分检测和传统临床病理因素对雌激素受体阳性(ER+)淋巴结阴性乳腺癌女性辅助临床决策的影响。
Ann Oncol. 2012 Mar;23(3):625-631. doi: 10.1093/annonc/mdr278. Epub 2011 Jun 6.
6
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
7
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.腋窝清扫与保留腋窝在伴有前哨淋巴结转移的浸润性乳腺癌女性中的随机临床试验
JAMA. 2011 Feb 9;305(6):569-75. doi: 10.1001/jama.2011.90.
8
Effect of occult metastases on survival in node-negative breast cancer.隐匿性转移对无淋巴结转移乳腺癌患者生存的影响。
N Engl J Med. 2011 Feb 3;364(5):412-21. doi: 10.1056/NEJMoa1008108. Epub 2011 Jan 19.
9
Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.与乳腺癌分子亚型预后和化疗敏感性相关的基因通路。
J Natl Cancer Inst. 2011 Feb 2;103(3):264-72. doi: 10.1093/jnci/djq524. Epub 2010 Dec 29.
10
Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer : beware of one-stop shops?术中放疗作为早期乳腺癌的加速部分乳腺照射:小心一站式服务?
Strahlenther Onkol. 2010 Dec;186(12):651-7. doi: 10.1007/s00066-010-8001-2.